←
MalmbergLab1,024 posts
MalmbergLab avatar

MalmbergLab

@MalmbergLab

The Malmberg Lab studies the functional regulation of natural killer (NK) cells and seeks to employ new insights in NK cell biology in cancer immunotherapy

◷ Joined January 2016▧ 106 Photos and videos
MalmbergLab avatar
MalmbergLab@MalmbergLab·5 Apr 2025

Great work, congrats. This is where we have to go.

Please check out our paper published in @NatureMedicine on our Phase I trial of AFM13-precomplexed cord blood NK cells in relapsed/refractory CD30+ lymphomas. Led by Dr. Yago Nieto and an outstanding team of coauthors and collaborators, this study marks the first clinical demonstration of NK cell redirection using a bispecific engager. We report an ORR of 92.9% and CR of 66.7% in 42 patients with a median of 7 prior therapies and show that this approach is safe and may serve as a bridge to SCT. Excited to move forward with our next generation engineered NK cells in combination with engagers and mAbs. #CancerResearch #Immunotherapy #NKcells @MDAndersonNews

MalmbergLab avatar
MalmbergLab@MalmbergLab·7 Jan 2025

Incredibly impressing ongoing work in the UK NK community. Thanks for the invitation @mjwsim. Looking forward to discussing more NK and KIR work in the coming days and to the yearly double 🎾 with @DrFran_Colucci

Wow. What an amazing day. So great to see so much great science about my favourite immune cells. Thanks to everyone who came and especially @MalmbergLab for a stellar keynote.

Post attachment
Katy Rezvani, M.D., Ph.D avatar
⟳ MalmbergLab retweeted
Katy Rezvani, M.D., Ph.D@lab_rezvani·11 Oct 2024

Working with a great team including @NathanSinghLab & Stephan Mielke to organize @KeystoneSymp Immune #CellTherapy: Advances in #Cancer and #AutoimmuneDisease Please join us to explore emerging research in Banff, March 16-19, 2025  | Fairmont Banff Springs, Banff, AB, Canada Scholarship Deadline: December 9, 2024 Short Talk Abstract Deadline: December 9, 2024 Poster Abstract Deadline: February 20, 2025 Early Registration Deadline: January 28 2025keysym.us/KSCellTherapy2… #KSCellTherapy25 pic.x.com/wb3hgSFKGz keystonesymposia.org/confere…

MalmbergLab avatar
MalmbergLab@MalmbergLab·27 Sep 2024

Very important and much needed funding to establish ATMP Norway, a multi-nodal national infrastructure for cell and gene therapy. Building on investments in GMP laboratories at @Oslounivsykehus and Haukeland University Hospital and a partnership with @UniOslo_MED.

Vi er svært glade for tildelingene fra @forskningsradet i dag, som bla. gir midler til å forsette å jobber med celle-genterapi, samt til forprosjekt for protonterapi. 1,3 milliardar kroner til forskingsinfrastruktur (forskningsradet.no)

MalmbergLab avatar
MalmbergLab@MalmbergLab·26 Sep 2024

Congrats @DanielPal88. Understanding the migratory behavior of NK cells is critical to overcome one of the major bottlenecks in the field: to make NK cells home to solid tumors. The inhibitory GPR56 axis is one piece of the puzzle.

Finally it's out and I can share with you all the collaborative effort done to produce this paper! Big thanks to @MalmbergLab and all the people who put so much effort into this. journals.aai.org/jimmunol/ar…

Malcolm Sim avatar
⟳ MalmbergLab retweeted
Malcolm Sim@mjwsim·9 Sep 2024

Exciting work by @AmirHorowitz and team! Congrats to all. HLA-E and NKG2A Mediate Resistance to M. bovis BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer biorxiv.org/content/10.1101/…

Quirin Hammer avatar
⟳ MalmbergLab retweeted
Quirin Hammer@QuirinHammer·8 Jul 2024

Taken together, in this study in @CellStemCell, we demonstrate that modulating the immune synapse can be a promising strategy to avert rejection by the host and hopefully further unlock 🔓 the potential of next-generation allogeneic #Immunotherapy against #cancer